Report cover image

Companion Diagnostics - Thematic Research

Publisher GlobalData
Published Mar 16, 2022
Length 32 Pages
SKU # GBDT17165916

Description

Companion Diagnostics - Thematic Research

Summary

Companion diagnostics (CDx) are molecular assays that measure levels of proteins, genes, or specific mutations to reveal a specific, efficacious therapy for an individual’s condition. CDx are a form of personalized, stratified, and precision medicine, and they herald a new era of treatment in which a patient’s treatment will become increasingly individualized.

CDx are developed in parallel to the drug using the drug-diagnostic co-development model. The field has expanded from a handful of oncology drugs with corresponding diagnostics to include multiple therapeutic areas, and the number of combinations has grown significantly over the years. However, oncology remains the largest segment for FDA-defined marketed drugs with CDx. The FDA has cleared or approved more than 40 CDx in the field of oncology. GlobalData expects that oncology will likely remain the therapeutic area at the forefront of CDx in the future. Although precision medicine encompasses many areas, oncology is the area that is expected to exhibit high growth.

This report looks at the CDx medical devices market and some of the oncology biomarkers, indications, and diagnostic technologies being utilized. The market for biomarker testing continues to increase due to increases in disease, awareness, improved accessibility to personalized medicine, and technological advancements.

Scope
  • This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
  • The report covers the companion diagnostics theme.
Reasons to Buy
  • GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
  • Develop and design your corporate strategies through an in-house expert analysis of companion diagnostics by understanding the primary ways in which this theme is impacting the medical devices industry.
  • Stay up to date on the industry’s major players and where they sit in the value chain.
  • Identify emerging industry trends to gain a competitive advantage.

Table of Contents

32 Pages
  • Executive Summary
    • Figure 1: Who are the leading players in the companion diagnostics theme and where do they sit in the value chain?
    • Immunohistochemistry
    • In Situ Hybridization
    • Nucleic Acid Amplification
    • Sanger Sequencing
    • Next-Generation Sequencing
    • Technology trends
    • Macroeconomic trends
    • Regulatory trends
    • BRCA
    • HER2
    • BRAF
    • BCR-ABL Tests
    • ALK Tests
    • Mergers and acquisitions
    • Timeline
    • Figure 8: Companion diagnostics value chain
    • Immunohistochemistry tests
    • In situ hybridization tests
    • Nucleic acid amplification tests
    • Sanger sequencing tests
    • Next-generation sequencing tests
    • Public companies
    • Private companies
    • GlobalData reports
    • Figure 14: Our five-step approach for generating a sector scorecard
  • About GlobalData
  • Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us